tiprankstipranks
Immatics N.V. (IMTX)
NASDAQ:IMTX
US Market
IMTX
Immatics
RESEARCH TOOLSreports
Want to see IMTX full AI Analyst Report?

Immatics (IMTX) Stock News & Sentiment

339 Followers
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
Premium
Company Announcements
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
12d ago
6K
IMTX
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
Premium
Company Announcements
Immatics Secures Four High-Profile Oral Slots for PRAME and Bispecific Programs at 2026 ASCO
1M ago
6K
IMTX
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
Premium
Company Announcements
Immatics Highlights PRAME-Targeted Cell Therapy Remission in Pediatric Kidney Cancer, Plans Pediatric Trial Expansion
1M ago
6K
IMTX
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
Premium
Company Announcements
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
3M ago
6K
IMTX
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
Premium
Company Announcements
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026
4M ago
6K
IMTX
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
Premium
Company Announcements
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
5M ago
6K
IMTX
Immatics Completes $116.5 Million Share Offering to Boost R&D
Premium
Company Announcements
Immatics Completes $116.5 Million Share Offering to Boost R&D
6M ago
6K
IMTX
More IMTX News >

IMTX News on the Web

Bank of America Securities Reaffirms Their Buy Rating on Immatics (IMTX)
TipRanks News
Bullish
Chardan Capital Reaffirms Their Buy Rating on Immatics (IMTX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Cormedix (CRMD)
TipRanks News
Neutral
Bank of America Securities Reaffirms Their Buy Rating on Immatics (IMTX)
TipRanks News
Bullish
Guggenheim Reaffirms Their Buy Rating on Immatics (IMTX)
TipRanks News
Bullish
Immatics (IMTX) Gets a Buy from Goldman Sachs
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: Olema Pharmaceuticals (OLMA), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
TipRanks News
Neutral
Immatics reports Q1 EPS (43c), consensus (44c)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
IMTX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.75 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMTX’s Media Buzz Sentiment?
2 articles about IMTX were published this week. In an average week, 2.75 articles are published.
    What is IMTX’s weekly average amount of articles?
    In an average week, 2.75 articles about IMTX are published.
      What is IMTX’s News Sentiment?
      99% of articles about IMTX were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week